A 2-hydroxy-1,2,3-propanetricarboxylic acid CEP of the European Pharmacopoeia monograph is often referred to as a 2-hydroxy-1,2,3-propanetricarboxylic acid Certificate of Suitability (COS). The purpose of a 2-hydroxy-1,2,3-propanetricarboxylic acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 2-hydroxy-1,2,3-propanetricarboxylic acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 2-hydroxy-1,2,3-propanetricarboxylic acid to their clients by showing that a 2-hydroxy-1,2,3-propanetricarboxylic acid CEP has been issued for it. The manufacturer submits a 2-hydroxy-1,2,3-propanetricarboxylic acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a 2-hydroxy-1,2,3-propanetricarboxylic acid CEP holder for the record. Additionally, the data presented in the 2-hydroxy-1,2,3-propanetricarboxylic acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 2-hydroxy-1,2,3-propanetricarboxylic acid DMF.
A 2-hydroxy-1,2,3-propanetricarboxylic acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 2-hydroxy-1,2,3-propanetricarboxylic acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 2-hydroxy-1,2,3-propanetricarboxylic acid suppliers with CEP (COS) on PharmaCompass.